首页> 中文期刊> 《中国医药指南》 >肺癌住院患者医院感染的病原菌分布及耐药分析

肺癌住院患者医院感染的病原菌分布及耐药分析

         

摘要

Objective To explore the distribution and drug resistance of pathogens of nosocomial infections in the lung cancer patients. Methods The clinical information and data of 271 inpatients with lung cancer from Jun 2005 to Jun 2013 were collected, then distribution and drug resistance of pathogens of nosocomial infections were analyzed. Results Totally 271 cases of lung cancer patients, the infections occurred in 47 cases with the infection rate of 17.34%.There were 51 times of case infection, with the rate of case infection times of 18.82%.The main infection site was respiratory system(72.54%).The pathogenic bacteria were gram-negative bacteria(55.32%),gram-positive bacteria(38.30%),and fungus(6.38%).Most of the pathogens were highly resistant to penicillin, ceftriaxone, and levofloxacin. Conclusion The lung cancer inpatients are the susceptible population. Medical staff should pay more attention to the related factors of the nosocomial infections, and take positive and effective measures for preventive control.%目的:了解肺癌患者医院感染的病原菌分布及耐药性。方法收集2005年6月至2013年6月入住我院的271例肺癌患者的临床资料,进行病原菌分布及耐药性情况分析。结果271例肺癌患者发生医院感染47例,感染率为17.34%,感染51例次,感染例次率18.82%;以呼吸系统感染为主,占72.54%;病原菌中革兰阴性菌、革兰阳性菌、真菌分别占55.32%、38.30%、6.38%;病原菌对青霉素、头孢曲松、左氧氟沙星等耐药率较高。结论肺癌患者是医院感染的易感人群,医务人员应针对肺癌患者院内感染的病原菌分布及耐药特点进行有效防控。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号